ID   JMUi001-A-1
AC   CVCL_ZL59
SY   DNAJC19tv; UKWCHFi002-A-1
DR   hPSCreg; JMUi001-A-1
DR   Wikidata; Q98126798
RX   PubMed=32521499;
CC   From: Comprehensive Heart Failure Center, University Clinic Wurzburg; Wurzburg; Germany.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 30528; DNAJC19.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
DI   NCIt; C173146; 3-methylglutaconic aciduria type 5
DI   ORDO; Orphanet_66634; Dilated cardiomyopathy with ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZL58 ! JMUi001-A
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 8
//
RX   PubMed=32521499; DOI=10.1016/j.scr.2020.101856;
RA   Janz A., Chen R.-P., Regensburger M., Ueda Y., Rost S., Klopocki E.,
RA   Gunther K., Edenhofer F., Duff H.J., Ergun S., Gerull B.;
RT   "Generation of two patient-derived iPSC lines from siblings
RT   (LIBUCi001-A and LIBUCi002-A) and a genetically modified iPSC line
RT   (JMUi001-A-1) to mimic dilated cardiomyopathy with ataxia (DCMA)
RT   caused by a homozygous DNAJC19 mutation.";
RL   Stem Cell Res. 46:101856-101856(2020).
//